Funding search · Alzheimer'S Disease Research Foundation · grants

Alzheimer'S Disease Research Foundation: all 448 grants

Largest first · $100.1M across 2022–2025 · back to the overview

$201,234
Brigham and Women'S Hospital · Boston, MA · 2025
T cell modulation of microglia to treat alzheimer's disease
$201,234
Brigham and Women'S Hospital · Boston, MA · 2024
T cell modulation of microglia to treat alzheimer's disease
$201,227
Massachusetts General Hospital · Boston, MA · 2024
Circuit dynamics in apoe4 mice
$201,212
Washington University in St Louis · St Louis, MO · 2025
Neuroprotective t cell-based therapy for alzheimer's disease
$201,199
The Methodist Hospital Foundation · Houston, TX · 2023
A muti-modality study on lipid molecular basis of obesity and its roles in regulating alzheimer's pathogenesis for developing potential targeted interventions
$201,167
Houston Methodist Research Institute (Houston Methodist Hospital Foundation · Houston, TX · 2025
A muti-modality study on lipid molecular basis of obesity and its roles in regulating alzheimer's pathogenesis for developing potential targeted interventions
$200,631
Indiana University · Bloomington, IN · 2024
Modulating the levels of tau-seed interactors to treat alzheimer's diseases
$200,568
University of Massachusetts Chan Medical School · Worcester, MA · 2025
Ventricular ependymal cells: a novel neural-immune signaling axis during aging and neurodegeneration
$200,532
Weill Medical College of Cornell University · New York, NY · 2025
Hypertension, tau and neurodegeneration
$200,532
Weill Medical College of Cornell University · New York, NY · 2024
Hypertension, tau and neurodegeneration
$200,530
Washington University in St Louis · St Louis, MO · 2025
Multiomic and functional characterization of strem2 modifiers
$200,417
Massachusetts General Hospital · Charlestown, MA · 2022
Circadian perturbations of the vasculome and microgliome in alzheimers disease
$200,416
Massachusetts General Hospital · Boston, MA · 2025
Circadian perturbations of the vasculome and microgliome in alzheimer's disease
$200,356
Washington University in St Louis · St Louis, MO · 2024
Multiomic and functional characterization of strem2 modifiers
$200,187
University of Kentucky · Lexington, KY · 2025
Lowering microglial lipid burden via plin2 modulation in alzheimer's disease
$200,043
University of Washington · Seattle, WA · 2025
Elucidating the therapeutic potential of the endo-lysosome pathway for alzheimer's disease
$200,000
Carnegie Mellon · Pittsburgh, PA · 2022
Circuits: interpreting alzheimers disease-associated genetic variation at enhancer regions
$199,995
Yale University · New Haven, CT · 2024
The role of calcium homeostasis in axonal spheroid formation in alzheimer's disease
$199,281
Washington University in St Louis · St Louis, MO · 2025
Circadian desynchrony, glial dysfunction, and alzheimer disease pathogenesis
$199,162
Duke · Durham, NC · 2022
Sex differences in alzheimer's disease progression: framingham heart study
$198,994
Washington University · St Louis, MO · 2023
Circadian desynchrony, glial dysfunction, and alzheimer's disease pathogenesis
$198,932
University of Virginia · Charlottesville, VA · 2022
Toxic effects of extracellular tau oligomers on neurons
$198,751
Stanford University · Redwood City, CA · 2023
Oligodendroglial dynamics and myelination in alzheimer's disease
$198,370
Stanford University · Redwood City, CA · 2025
Oligodendroglial dynamics and myelination in alzheimer's disease
$198,253
Stanford University · Redwood City, CA · 2025
Bmp lipid metabolism as a therapeutic target for lysosomal function and alzheimer's disease pathogenesis
$197,500
Boston University · Boston, MA · 2022
Ad4: blocking synaptotoxicity in alzheimer's 3d models
$197,500
Massachusetts General Hospital · Charlestown, MA · 2022
Ad4: modulating cd33 function and neuroinflammation as a therapeutic approach for alzheimers disease
$195,434
Duke University School of Medicine · Durham, NC · 2023
Contributions of il34 signaling to microglial function and alzheimer's pathology in mice
$195,250
Brigham and Women'S Hospital · Boston, MA · 2024
Targeting neuroinflammation with nasal administration of anti-cd3 monoclonal antibody to treat alzheimer's disease
$194,253
Duke · Durham, NC · 2022
Contributions of il34 signaling to microglial function and alzheimers pathology in mice
$192,314
Duke University School of Medicine · Durham, NC · 2024
Contributions of il34 signaling to microglial function and alzheimer's pathology in mice
$192,020
University of Virginia · Charlottesville, VA · 2023
Toxic effects of extracellular tau oligomers on neurons
$191,463
University of California Los Angeles · Los Angeles, CA · 2025
Novel ai decodes aging neurons
$189,902
Washington University · St Louis, MO · 2023
Deciphering and restoring computational set-points in alzheimer's disease through sleep-enhanced network homeostasis
$189,750
Boston Children'S Hospital · Boston, MA · 2023
Neuroinflammation at the choroid plexus in alzheimer's disease
$187,315
President and Fellows of Harvard College · Cambridge, MA · 2024
Harvard t.h. Chan school of public health-precision medicine prediction model for alzheimer's disease using cooperative learning approaches for multi-omic data
$183,562
Brigham and Women'S · Boston, MA · 2022
Immunotherapies targeting the microbiota to prevent cognitive decline in alzheimer's disease
$182,921
Washington University in St Louis · St Louis, MO · 2025
Mapping the x chromosome multi-ome in alzheimer's and parkinson's disease
$181,004
University of Texas Health Science Center at San Antonio · San Antonio, TX · 2025
Bridging myelin and vascular dementia: oligodendrocyte stress responses in ageing and cerebrovascular disease
$180,419
Indiana University · Bloomington, IN · 2024
Relationship between alzheimer's disease risk and outcomes of mild repetitive neurotrauma
$177,675
Massachusetts General Hospital · Charlestown, MA · 2022
G2t, ad4 and general scientific support
$175,000
Seattle Neurosound Solutions · Seattle, WA · 2025
Continuous monitoring and enhancement of glymphatic flow in human sleep
$174,883
New York University · New York, NY · 2022
The role of astrocyte-derived toxic lipids mediating degeneration in alzheimers disease
$173,007
Burke Neurological Institute · White Plains, NY · 2025
2-deoxyglucose and its analogs as novel therapeutics to build resilience to alzheimer's disease
$173,007
Burke Neurological Institute · White Plains, NY · 2024
2-deoxyglucose and its analogs as novel therapeutics to build resilience to alzheimer's disease
$172,550
Broad Institute · Cambridge, MA · 2023
Revealing new genes and pathways at the intersection of lipotoxic and genetic risk for alzheimer's disease
$172,500
Icahn School of Medicine at Mount Sinai · New York, NY · 2024
Vgf-derived peptide therapy for ad: studies of mouse and human tlqp-21 and its receptor, c3ar1
$172,500
Massachusetts General Hospital · Boston, MA · 2024
Neuroprotective effects of the exercise hormone irisin in alzheimer's disease
$172,500
Icahn Scool of Medicine at Mount Sinai · New York, NY · 2023
Stress and neurovascular-immune networks in alzheimer's disease
$172,500
Icahn Scool of Medicine at Mount Sinai · New York, NY · 2023
Investigating bone marrow hematopoiesis and the link between sleep fragmentation and vascular inflammation in ad
$172,500
Icahn Scool of Medicine at Mount Sinai · New York, NY · 2023
In vivo models for golgi fragmentation and the molecular pathogenesis of alzheimer's disease
$172,500
Massachusetts General Hospital · Boston, MA · 2023
Tau and -amyloid are innate immune antimicrobial peptides in the brain
$172,500
Mayo Clinic Jacksonville · Jacksonville, FL · 2023
Targeting microglial tsg 101 for synaptic protection and cognitive enhancement in alzheimer's disease
$172,500
Northwestern University · Chicago, IL · 2023
T cell epigenetics in alzheimer's disease
$172,500
The Salk Institute for Biologial Studies · La Jolla, CA · 2023
The role of astrocyte-secreted igfbp2 in the progression of alzheimer's disease
$172,500
Washington University · St Louis, MO · 2023
Understanding the role of natural a-specific b cell responses in ad progression
$172,500
Brigham and Women'S · Boston, MA · 2022
Role of checkpoint molecule tim-3 in microglia regulation in alzheimers disease
$172,500
Massachusetts General Hospital · Charlestown, MA · 2022
Effects of de-palmitoylation and acat inhibition on axonal ab generation via mam-associated palapp
$172,500
Massachusetts General Hospital · Charlestown, MA · 2022
Neuroprotective effects of the exercise hormone irisin in alzheimers disease
$172,500
Massachusetts General Hospital · Charlestown, MA · 2022
Regional variability of pathology-associated properties of tau in posterior cortical atrophy
$172,500
Massachusetts General Hospital · Charlestown, MA · 2022
Development of a multicellular brain model to study brain-vascular-peripheral immune cells crosstalk inalzheimers disease
$172,500
Mayo Jacksonville · Jacksonville, FL · 2022
Harnessing meningeal lymphatics and immunity to alleviate apoe4-induced brain dysfunction
$172,500
Mount Sinai · New York, NY · 2022
Systems integration and therapeutics translation in alzheimers disease
$172,500
Mount Sinai · New York, NY · 2022
Stress and neurovascular-immune networks in alzheimers disease
$172,500
Mount Sinai · New York, NY · 2022
Establishing the molecular and cellular mechanisms and biomarkers of apoe4-mediated susceptibility to tau-related cognitive impairments
$172,500
Mskcc · New York, NY · 2022
The role of ifitm3 and gamma secretase in microglia
$172,500
Rockefeller · New York, NY · 2022
Stimulating synaptic proteasome activity for the treatment of alzheimers disease
$172,500
Stanford · Stanford, CA · 2022
A transcriptional rejuvenation signature for alzheimers disease
$172,500
Tufts · Boston, MA · 2022
In vivo characterization of a loss of function gga3 rare variant associated with ad
$172,500
Unc-Chapel Hill · Chapel Hill, NC · 2022
Small molecule activators of plc-y2 as novel therapeutics for alzheimers disease
$172,500
University of California San Diego · La Jolla, CA · 2022
Functional basis for novel pkc k56r mutation in alzheimer's disease
$172,500
University of Virginia · Charlottesville, VA · 2022
Targeting a master innate immune adaptor molecule in alzheimers disease
$172,500
Wake Forest · Winstonsalem, NC · 2022
Investigating the role of tau protein in neuronal senescence induction and maintenance
$172,500
Washington University · St Louis, MO · 2022
Contribution of skull bone marrow-derived cells to alzheimers disease
$172,500
Washington University · St Louis, MO · 2022
Neuronal subtype-specific modeling of alzheimers disease by direct neuronal reprogramming of patient fibroblasts
$172,500
Washington University · St Louis, MO · 2022
Targeting reactive astrocytes for therapeutic intervention of alzheimers disease
$172,500
Weill Cornell · New York, NY · 2022
Gut microbiota, endothelial dysfunction and tau-mediated cognitive impairment
$172,500
Weill Cornell · New York, NY · 2022
Role of microglia in degradation and trimming of alzheimers amyloid beta
$172,500
Weill Cornell · New York, NY · 2022
Identification of cd33 antagonists
$172,500
Yale · New Haven, CT · 2022
Role of microglial matricellular protein sparc in control of inflammasome activation
$172,000
Massachusetts General Hospital · Boston, MA · 2023
Regional variability of pathology-associated properties of tau in posterior cortical atrophy
$171,207
Broad Institute · Cambridge, MA · 2022
Revealing new genes and pathways at the intersection of lipotoxic and genetic risk for alzheimers disease
$171,037
State of Maryland -University of Maryland Baltimore · Baltimore, MD · 2025
Expanding postmortem brain resources for alzheimer's disease in diverse populations
$170,877
Barrow · Phoenix, AZ · 2022
Harnessing big data to understand alzheimer's disease risk
$167,707
Boston University · Boston, MA · 2022
Apoe consortium: modulation of selective neuronal vulnerability in alzheimers disease by apoe
$167,637
Baylor College of Medicine · Houston, TX · 2022
Elucidating the role of soluble epoxide hydrolase and arachidonic acid metabolism in neuroinflammation and alzheimers disease
$150,937
Regents of the University of California San Diego · La Jolla, CA · 2025
The role of planar cell polarity proteins in tau oligomer-induced synapse degeneration
$150,786
Icahn School of Medicine at Mount Sinai · New York, NY · 2025
Alzheimer's disease pet imaging of nonfibrillar amyloid beta aggregates using azapeptide (azp) tracer
$150,786
Icahn School of Medicine at Mount Sinai · New York, NY · 2024
Alzheimer's disease pet imaging of nonfibrillar amyloid beta aggregates using azapeptide (azp) tracer
$150,000
Harvard Medical School · Cambridge, MA · 2023
Precision medicine prediction model for alzheimer's disease using cooperative learning approaches for multi-omic data
$149,500
Boston Children'S Hospital · Boston, MA · 2022
Neuroinflammation contributions to alzheimers disease: role of the choroid plexus
$148,773
University of Michigan · Ann Arbor, MI · 2024
Non-invasive delivery of il-2 to the cns for local expansion of tregs and prevention of neurodegeneration in tauopatthy
$143,697
Johns Hopkins University · Baltimore, MD · 2025
Bridge funding for a younger diverse human brain bank to investigate early ad pathology
$138,000
Baylor College of Medicine · Houston, TX · 2025
Decipher the astrocyte cell-surface proteome in alzheimer's disease
$138,000
Baylor College of Medicine · Houston, TX · 2024
Decipher the astrocyte cell-surface proteome in alzheimer's disease
$136,827
Northwestern University · Chicago, IL · 2023
Interrogating levetiracetam's impact on amyloid pathology and presynaptic proteostasis in knock-in mouse models with humanized abeta
$125,000
Massachusetts General Hospital · Boston, MA · 2024
The impact of mutations in the ligand-binding domain of cd33 on alzheimer's disease pathogenesis
$125,000
Massachusetts General Hospital · Boston, MA · 2023
The impact of mutations in the ligand-binding domain of cd33 on alzheimer's disease pathogenesis
$124,653
Washington University in St Louis · St Louis, MO · 2025
Characterization of alzheimer's disease molecular biomarker profiles throughout the pathobiological continuum
$123,098
Washington University in St Louis · St Louis, MO · 2024
Characterization of molecular biomarker profiles throughout the pathobiological continuum